NO303779B1 - Imidazolforbindelser, anvendelse derav og farmas°ytisk preparat - Google Patents
Imidazolforbindelser, anvendelse derav og farmas°ytisk preparatInfo
- Publication number
- NO303779B1 NO303779B1 NO931080A NO931080A NO303779B1 NO 303779 B1 NO303779 B1 NO 303779B1 NO 931080 A NO931080 A NO 931080A NO 931080 A NO931080 A NO 931080A NO 303779 B1 NO303779 B1 NO 303779B1
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- amino
- alkoxy
- nitro
- halogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Polymerization Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK92401A DK40192D0 (da) | 1992-03-26 | 1992-03-26 | Imidazolforbindelser, deres fremstilling og anvendelse |
Publications (3)
Publication Number | Publication Date |
---|---|
NO931080D0 NO931080D0 (no) | 1993-03-24 |
NO931080L NO931080L (no) | 1993-09-27 |
NO303779B1 true NO303779B1 (no) | 1998-08-31 |
Family
ID=8093115
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO931080A NO303779B1 (no) | 1992-03-26 | 1993-03-24 | Imidazolforbindelser, anvendelse derav og farmas°ytisk preparat |
Country Status (15)
Country | Link |
---|---|
US (1) | US5360809A (ja) |
EP (1) | EP0563001B1 (ja) |
JP (1) | JP3647051B2 (ja) |
KR (1) | KR100286844B1 (ja) |
AT (1) | ATE134621T1 (ja) |
AU (1) | AU660219B2 (ja) |
CA (1) | CA2092211C (ja) |
DE (1) | DE69301618T2 (ja) |
DK (2) | DK40192D0 (ja) |
ES (1) | ES2085133T3 (ja) |
FI (1) | FI931305A (ja) |
GR (1) | GR3019204T3 (ja) |
NO (1) | NO303779B1 (ja) |
NZ (1) | NZ247233A (ja) |
ZA (1) | ZA932090B (ja) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU675484B2 (en) * | 1993-03-24 | 1997-02-06 | Neurosearch A/S | Benzimidazole compounds, their use and preparation |
US5554630A (en) * | 1993-03-24 | 1996-09-10 | Neurosearch A/S | Benzimidazole compounds |
CN1142817A (zh) * | 1993-10-12 | 1997-02-12 | 杜邦麦克制药有限公司 | 1n-烷基-n-芳基嘧啶胺及其衍生物 |
EP0723533A1 (en) * | 1993-10-12 | 1996-07-31 | The Du Pont Merck Pharmaceutical Company | 1n-alkyl-n-arylpyrimidinamines and derivatives thereof |
US5552426A (en) * | 1994-04-29 | 1996-09-03 | Eli Lilly And Company | Methods for treating a physiological disorder associated with β-amyloid peptide |
EE04308B1 (et) * | 1995-04-21 | 2004-06-15 | Neurosearch A/S | Bensimidasooli ühendid, neid ühendeid sisaldavad farmatseutilised kompositsioonid ja nende kasutamine |
US6228871B1 (en) | 1995-07-10 | 2001-05-08 | Merck & Co., Inc. | Angiogenesis inhibitors |
UA49006C2 (uk) * | 1996-03-29 | 2002-09-16 | Файзер Інк. | Похідні 6-фенілпіридил-2-аміну, фармацевтична композиція, спосіб інгібування синтази оксиду нітрогену у ссавців та спосіб лікування |
NZ334868A (en) * | 1996-10-21 | 2001-02-23 | Neurosearch As | 1-Phenyl-benzimidazole compounds and their use as BAGA-a receptor modulators |
GB9702524D0 (en) * | 1997-02-07 | 1997-03-26 | Merck Sharp & Dohme | Therapeutic agents |
US5990146A (en) * | 1997-08-20 | 1999-11-23 | Warner-Lambert Company | Benzimidazoles for inhibiting protein tyrosine kinase mediated cellular proliferation |
WO1999016755A1 (en) * | 1997-09-26 | 1999-04-08 | Merck & Co., Inc. | Novel angiogenesis inhibitors |
US6162804A (en) * | 1997-09-26 | 2000-12-19 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
US6465484B1 (en) | 1997-09-26 | 2002-10-15 | Merck & Co., Inc. | Angiogenesis inhibitors |
US6541479B1 (en) * | 1997-12-02 | 2003-04-01 | Massachusetts College Of Pharmacy | Calcium channel blockers |
CA2341409A1 (en) * | 1998-08-31 | 2000-03-09 | Merck And Co., Inc. | Novel angiogenesis inhibitors |
AU760250B2 (en) * | 1998-12-04 | 2003-05-08 | Neurosearch A/S | New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents |
UA71945C2 (en) * | 1999-01-27 | 2005-01-17 | Pfizer Prod Inc | Substituted bicyclic derivatives being used as anticancer agents |
JP3270834B2 (ja) | 1999-01-27 | 2002-04-02 | ファイザー・プロダクツ・インク | 抗がん剤として有用なヘテロ芳香族二環式誘導体 |
RU2243226C2 (ru) * | 1999-06-22 | 2004-12-27 | НьюроСёрч А/С | Новые производные бензимидазола и содержащие эти соединения фармацевтические композиции |
GB9921150D0 (en) | 1999-09-07 | 1999-11-10 | Merck Sharp & Dohme | Therapeutic agents |
JP2004501109A (ja) | 2000-05-24 | 2004-01-15 | メルク シャープ エンド ドーム リミテッド | Gaba受容体に対するリガンドとしての3−フェニル−イミダゾ−ピリミジン誘導体 |
US7022480B1 (en) | 2001-10-11 | 2006-04-04 | The Regents Of The University Of California | Exons of the hSKCa3/KCNN3 gene |
GB0208392D0 (en) * | 2002-04-11 | 2002-05-22 | Merck Sharp & Dohme | Therapeutic compounds |
GB0208394D0 (en) * | 2002-04-11 | 2002-05-22 | Merck Sharp & Dohme | Therapeutic agents |
GB0212048D0 (en) * | 2002-05-24 | 2002-07-03 | Merck Sharp & Dohme | Therapeutic agents |
CN101503393B (zh) * | 2003-03-13 | 2015-08-19 | 出光兴产株式会社 | 含氮杂环衍生物及使用该衍生物的有机电致发光元件 |
WO2004087690A2 (en) * | 2003-04-03 | 2004-10-14 | Neurosearch A/S | Benzimidazole derivatives and their use for modulating the gaba-a receptor complex |
US7442709B2 (en) | 2003-08-21 | 2008-10-28 | Osi Pharmaceuticals, Inc. | N3-substituted imidazopyridine c-Kit inhibitors |
CN1852905A (zh) * | 2003-08-21 | 2006-10-25 | Osi制药公司 | 具有n-取代的苯并咪唑基的c-kit抑制剂 |
US7504401B2 (en) | 2003-08-29 | 2009-03-17 | Locus Pharmaceuticals, Inc. | Anti-cancer agents and uses thereof |
RU2006118312A (ru) * | 2003-10-28 | 2007-12-10 | Вертекс Фармасьютикалз Инкорпорейтед (Us) | Бензимидазолы, полезные в качестве модуляторов ионных каналов |
ES2330468T3 (es) * | 2005-04-13 | 2009-12-10 | Neurosearch A/S | Derivados de benzimidazol y su uso para modular el complejo del receptor gabaa. |
US7705002B2 (en) * | 2005-05-19 | 2010-04-27 | Vertex Pharmaceuticals Incorporated | Biaryls useful as modulators of ion channels |
WO2007007463A1 (ja) * | 2005-07-11 | 2007-01-18 | Idemitsu Kosan Co., Ltd. | 電子吸引性置換基を有する含窒素複素環誘導体及びそれを用いた有機エレクトロルミネッセンス素子 |
JP4738419B2 (ja) * | 2005-11-30 | 2011-08-03 | 富士フイルムRiファーマ株式会社 | アミロイドの凝集及び/又は沈着に起因する疾患の診断薬及び治療薬 |
KR20080077620A (ko) * | 2005-12-05 | 2008-08-25 | 뉴로서치 에이/에스 | 벤즈이미다졸 및 gabaa 수용체 복합체를 조절하기위한 이의 용도 |
TWI391381B (zh) * | 2006-03-24 | 2013-04-01 | Neurosearch As | 新穎的苯并咪唑衍生物、含有其之醫藥組成物、及其於製造藥物之用途 |
EP2172454A4 (en) * | 2007-07-24 | 2010-12-08 | Astellas Pharma Inc | benzimidazole derivative |
WO2009133070A1 (en) * | 2008-04-29 | 2009-11-05 | Novartis Ag | Imidazo-pyridine derivatives as activin-like receptor kinase (alk4 or alk5) inhibitors |
TW201029986A (en) | 2008-11-14 | 2010-08-16 | Neurosearch As | Novel compounds |
WO2010055130A1 (en) * | 2008-11-14 | 2010-05-20 | Neurosearch A/S | Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
TW201029987A (en) * | 2008-11-14 | 2010-08-16 | Neurosearch As | Novel compounds |
WO2010055133A1 (en) * | 2008-11-14 | 2010-05-20 | Neurosearch A/S | Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
JPWO2010087319A1 (ja) | 2009-01-27 | 2012-08-02 | アステラス製薬株式会社 | 前立腺癌治療剤として有効な物質のスクリーニング方法 |
US8278460B2 (en) * | 2009-10-15 | 2012-10-02 | Concert Pharmaceuticals, Inc. | Substituted benzimidazoles |
WO2012131501A1 (en) * | 2011-03-28 | 2012-10-04 | Glenmark Pharmaceuticals S.A. | Substituted benzimidazole compounds as cot kinase inhibitors |
AU2014247941C1 (en) * | 2013-04-04 | 2019-10-31 | University Of Maryland, Baltimore | Nonsteroidal and steroidal compounds with potent androgen receptor down-regulation and anti prostate cancer activity |
MX2021012305A (es) * | 2019-04-12 | 2021-11-12 | Riboscience Llc | Derivados de heteroarilos biciclicos como inhibidores de ectonucleotido pirofosfatasa fosfodiesterasa 1. |
CN112142622A (zh) * | 2020-11-02 | 2020-12-29 | 江苏宝众宝达药业有限公司 | 一种4-氟-3-硝基苯腈的合成方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1570893A (ja) * | 1968-06-18 | 1969-06-13 | ||
HU190412B (en) * | 1981-09-17 | 1986-09-29 | Warner-Lambert Co,Us | Process for producing substituted 4,5-dihiydro-6-bracket-substituted-bracket closed-phenyl-3-bracket-2h-bracket closed-pyridazinones and 6-bracket-substituted-bracket closed-phenyl-3-bracket-2h-bracket closed-pyridazinones |
US4492708A (en) * | 1982-09-27 | 1985-01-08 | Eli Lilly And Company | Antiviral benzimidazoles |
US4734415A (en) * | 1982-08-13 | 1988-03-29 | Warner-Lambert Company | Substituted 4,5-dihydro-6-(substituted)-phenyl-3(2H)-pyridazinones and 6-(substituted) phenyl-3(2H)-pyridazinones |
US4503061A (en) * | 1983-07-22 | 1985-03-05 | Warner-Lambert Company | Substituted phenyl-pyridinones as cardiotonic agents |
JPS59185691A (ja) * | 1983-04-06 | 1984-10-22 | Ricoh Co Ltd | ジアゾ系感熱記録材料 |
US4550119A (en) * | 1983-05-23 | 1985-10-29 | Warner-Lambert Company | 2,4-Dihydro-5-[(substituted)phenyl]-4,4-disubstituted-3H-pyrazol-3-ones |
JPS61151176A (ja) * | 1984-12-24 | 1986-07-09 | Sumitomo Chem Co Ltd | ベンズイミダゾール誘導体およびそれを有効成分とする殺虫、殺ダニ剤 |
MY104933A (en) * | 1987-09-30 | 1994-07-30 | Pfizer Ltd | Platelet activating factor antagonists |
FR2643903A1 (fr) * | 1989-03-03 | 1990-09-07 | Union Pharma Scient Appl | Nouveaux derives de benzimidazole, leurs procedes de preparation, intermediaires de synthese, compositions pharmaceutiques les contenant, utiles notamment pour le traitement des maladies cardiovasculaires, et des ulceres duodenaux |
US5294631A (en) * | 1990-04-13 | 1994-03-15 | Smithkline Beecham Corporation | Substituted benzimidazoles useful as angiotension II receptor antagonists |
GB9010637D0 (en) * | 1990-05-11 | 1990-07-04 | Secr Defence | A high frequency multichannel diversity differential phase shift(dpsk)communications system |
DE4015535A1 (de) * | 1990-05-15 | 1991-11-21 | Basf Ag | Verfahren zur herstellung von n-substituierten imidazolen |
PH31175A (en) * | 1990-10-31 | 1998-03-20 | Squibb & Sons Inc | Indole and benzimi-dazole-substituted imidazole and benzimidazole derivatives. |
US5210091A (en) * | 1991-06-24 | 1993-05-11 | Neurosearch A/S | Imidazole compounds and their use |
ATE163290T1 (de) * | 1991-06-24 | 1998-03-15 | Neurosearch As | Imidazol-verbindungen, verfahren zu ihrer herstellung und ihre anwendung |
-
1992
- 1992-03-26 DK DK92401A patent/DK40192D0/da not_active Application Discontinuation
-
1993
- 1993-03-23 CA CA002092211A patent/CA2092211C/en not_active Expired - Fee Related
- 1993-03-24 EP EP93610022A patent/EP0563001B1/en not_active Expired - Lifetime
- 1993-03-24 KR KR1019930004595A patent/KR100286844B1/ko not_active IP Right Cessation
- 1993-03-24 JP JP06568893A patent/JP3647051B2/ja not_active Expired - Fee Related
- 1993-03-24 NO NO931080A patent/NO303779B1/no unknown
- 1993-03-24 DE DE69301618T patent/DE69301618T2/de not_active Expired - Lifetime
- 1993-03-24 ZA ZA932090A patent/ZA932090B/xx unknown
- 1993-03-24 NZ NZ247233A patent/NZ247233A/en not_active IP Right Cessation
- 1993-03-24 ES ES93610022T patent/ES2085133T3/es not_active Expired - Lifetime
- 1993-03-24 FI FI931305A patent/FI931305A/fi unknown
- 1993-03-24 US US08/036,425 patent/US5360809A/en not_active Expired - Lifetime
- 1993-03-24 AT AT93610022T patent/ATE134621T1/de not_active IP Right Cessation
- 1993-03-24 DK DK93610022.1T patent/DK0563001T3/da active
- 1993-03-24 AU AU35406/93A patent/AU660219B2/en not_active Ceased
-
1996
- 1996-03-05 GR GR960400608T patent/GR3019204T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0563001A1 (en) | 1993-09-29 |
NO931080L (no) | 1993-09-27 |
AU660219B2 (en) | 1995-06-15 |
JP3647051B2 (ja) | 2005-05-11 |
CA2092211A1 (en) | 1993-09-27 |
AU3540693A (en) | 1993-09-30 |
DE69301618T2 (de) | 1996-08-22 |
NO931080D0 (no) | 1993-03-24 |
DE69301618D1 (de) | 1996-04-04 |
FI931305A (fi) | 1993-09-27 |
EP0563001B1 (en) | 1996-02-28 |
ES2085133T3 (es) | 1996-05-16 |
US5360809A (en) | 1994-11-01 |
KR100286844B1 (ko) | 2001-04-16 |
NZ247233A (en) | 1995-03-28 |
JPH0649037A (ja) | 1994-02-22 |
CA2092211C (en) | 2003-08-26 |
FI931305A0 (fi) | 1993-03-24 |
ZA932090B (en) | 1993-10-15 |
DK0563001T3 (da) | 1996-08-05 |
GR3019204T3 (en) | 1996-06-30 |
KR930019638A (ko) | 1993-10-18 |
ATE134621T1 (de) | 1996-03-15 |
DK40192D0 (da) | 1992-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO303779B1 (no) | Imidazolforbindelser, anvendelse derav og farmas°ytisk preparat | |
DK154092D0 (da) | Imidazolforbindelser, deres fremstilling og anvendelse | |
TR28430A (tr) | N-asetonil benzamidler ve bunlarin fungisid olarak kullanimi. | |
NZ238181A (en) | N-(1-substituted-piperidinyl(alkyl))carbamic acid, urea and carboxamide derivatives and homologues thereof; preparatory processes and pharmaceutical compositions | |
BR9400808A (pt) | Composto, processo para sua preparação, composição fungicida, método de combater fungos e uso | |
PT669920E (pt) | 3-aminoalquilamino-1,2-benzoxazoles substituidos ecompostos relacionados | |
ZA929268B (en) | Imidazole compounds, their preparation and use. | |
PL306537A1 (en) | Substituted (aryloaloxybenzyl) amino propanamide derivatives, method of obtaining them and their application as antiepileptic, nervous system protecting and antidepressive agents | |
PT90725A (pt) | Processo para a preparacao de novos compostos cefem | |
BG106814A (en) | Quaternary salts of n-substituted cyclic or acyclic amines as pharmaceuticals | |
BR9304780A (pt) | Composto, processo para preparar o composto, composição farmacêutica e uso | |
BR9400015A (pt) | Processo para preparação de compostos e compostos | |
BR8404805A (pt) | Processo para a preparacao de derivados de hidroxietilazoliloxina composicoes fungicidas,processos para combater fungos e para a preparacao de composicoes | |
MX9100477A (es) | Derivados de halogenoalquil-azolilo y proceso para su preparacion | |
DK0420091T3 (da) | Anilinderivater | |
ES2125574T3 (es) | Procedimiento para la preparacion de (-)-n-metil-n-(4-(4-fenil-4-acetilaminopiperidin-1-il)-2-(3,4-diclorofenil)butil)-benzamida y sus sales farmaceuticamente aceptables. | |
PT911336E (pt) | Derivados do acido piridonacarboxilico e intermediarios para a sua sintese | |
BR8301067A (pt) | Processo para a preparacao de eteres azoliletil-oximinoalquilicos substituidos,composicoes fungicidas,processos para o combate de fungos e para a preparacao de composicoes |